Steven B. Abramson

Steven B. Abramson

Auto-generated profile, based on publicly available information

Steven B. Abramson

New York University School of Medicine, New York, New York

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2013 in eLife
Verified
Journal Article
Open access
JSJose U Scher
Jose U Scher
ASAndrew Sczesnak
Andrew Sczesnak
RLRandy S Longman
Randy S Longman
NSNicola Segata
Nicola Segata
CÚCarles Úbeda
Carles Úbeda
DLDan R Littman
Dan R Littman
Rheumatoid arthritis (RA) is a prevalent systemic autoimmune disease, caused by a combination of genetic and environmental factors. Animal models suggest a role for intestinal bacteria in supporting the systemic immune response required for joint inflammation. Here we performed 16S sequencing on 114 stool samples from rheumatoid arthritis patients and controls, and shotgun sequencing on a subset of 44 such samples. We identified the presence of Prevotella copri as strongly correlated with disease in new-onset untreated rheumatoid arthritis (NORA) patients. Increases in Prevotella abundance correlated with a reduction in Bacteroides and a loss of reportedly beneficial microbes in NORA subjects. We also identified unique Prevotella genes that correlated with disease. Further, colonization of mice revealed the ability of P. copri to dominate the intestinal microbiota and resulted in an increased sensitivity to chemically induced colitis. This work identifies a potential role for P. copri in the pathogenesis of RA.

6 June 2001 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
JPJean-Pierre Pelletier
Jean-Pierre Pelletier
JMJohanne Martel-Pelletier
Johanne Martel-Pelletier
SASteven B. Abramson
Steven B. Abramson

15 October 2014 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
JSJose U. Scher
Jose U. Scher
CÚCarles Úbeda
Carles Úbeda
AAAlejandro Artacho
Alejandro Artacho
MUKUNDAN ATTURMUKUNDAN ATTUR
MUKUNDAN ATTUR
SISandrine Isaac
Sandrine Isaac
SASteven B. Abramson
Steven B. Abramson
Objective: To characterize the diversity and taxonomic relative abundance of the gut microbiota in patients with never‐treated, recent‐onset psoriatic arthritis (PsA).Methods: High‐throughput 16S ribosomal RNA pyrosequencing was utilized to compare the community composition of gut microbiota in patients with PsA (n = 16), patients with psoriasis of the skin (n = 15), and healthy, matched control subjects (n = 17). Samples were further assessed for the presence and levels of fecal and serum secretory IgA (sIgA), proinflammatory proteins, and fatty acids.Results: The gut microbiota observed in patients with PsA and patients with skin psoriasis was less diverse when compared to that in healthy controls. This could be attributed to the reduced presence of several taxa. Samples from both patient groups showed a relative decrease in abundance of Coprococcus species, while samples from PsA patients were also characterized by a significant reduction in Akkermansia, Ruminococcus, and Pseudobutyrivibrio. Supernatants of fecal samples from PsA patients revealed an increase in sIgA levels and decrease in RANKL levels. Analysis of fatty acids revealed low fecal quantities of hexanoate and heptanoate in both patients with PsA and patients with psoriasis.Conclusion: Patients with PsA and patients with skin psoriasis had a lower relative abundance of multiple intestinal bacteria. Although some genera were concomitantly decreased in both conditions, PsA samples had a lower abundance of reportedly beneficial taxa. This gut microbiota profile in PsA was similar to that previously described in patients with inflammatory bowel disease and was associated with changes in specific inflammatory proteins unique to this group, and distinct from that in patients with skin psoriasis and healthy controls. Thus, the role of the gut microbiome in the continuum of psoriasis–PsA pathogenesis and the associated immune response merits further study.

22 April 2011 in Science
Verified
Journal Article
Closed access
PDF file
WTWei Tang
Wei Tang
YLYi Lu
Yi Lu
QTQing-Yun Tian
Qing-Yun Tian
YZYan Zhang
Yan Zhang
FGFeng-Jin Guo
Feng-Jin Guo
CLChuanju Liu
Chuanju Liu
A growth factor protects against arthritis in mice by blocking tumor necrosis factor–dependent signaling.

1 June 2006 in Clinical Immunology
Verified
Journal Article
Closed access
JPJean Y. Park
Jean Y. Park
MPMichael H. Pillinger
Michael H. Pillinger
SASteven B. Abramson
Steven B. Abramson

1 September 1992 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
RCR M Clancy
R M Clancy
JLJ Leszczynska-Piziak
J Leszczynska-Piziak
SAS B Abramson
S B Abramson
Nitric oxide provokes vasodilation and inhibits platelet aggregation. We examined the effect of nitric oxide on superoxide anion production by three sources: activated intact neutrophils, xanthine oxidase/hypoxanthine, and the NADPH oxidase. Nitric oxide significantly inhibited the generation of superoxide anion by neutrophils exposed to either FMLP (10(-7)M) or PMA (150 ng/ml) (IC50 = 30 microM). To determine whether the effect of nitric oxide on the respiratory burst was due to simple scavenging of O2+, kinetic studies that compared effects on neutrophils and the cell-free xanthine oxidase system were performed. Nitric oxide inhibited O2+ produced by xanthine oxidase only when added simultaneously with substrate, consistent with the short half-life of NO in oxygenated solution. In contrast, the addition of nitric oxide to neutrophils 20 min before FMLP resulted in the inhibition of O2+ production, which suggests formation of a stable intermediate. The effect of nitric oxide on the cell-free NADPH oxidase superoxide-generating system was also examined: The addition of NO before arachidonate activation (t = -6 min) significantly inhibited superoxide anion production. Nitric oxide did not inhibit O2+ when added at NADPH initiation (t = 0). Treatment of the membrane but not cytosolic component of the oxidase was sufficient to inhibit O2+ generation. The data suggest that nitric oxide inhibits neutrophil O2+ production via direct effects on membrane components of the NADPH oxidase. This action must occur before the assembly of the activated complex.